-
1
-
-
0026829361
-
Ovarian cancer. Part II. Treatment
-
Ozols, R. F. Ovarian cancer. Part II. Treatment. Curr. Prob. Cancer. 16: 63-126, 1992.
-
(1992)
Curr. Prob. Cancer.
, vol.16
, pp. 63-126
-
-
Ozols, R.F.1
-
2
-
-
38449122340
-
The mechanism of action of platinum anti-tumor drugs
-
Reedijk, J. The mechanism of action of platinum anti-tumor drugs. Pure Appl. Chem., 59: 181-192, 1987.
-
(1987)
Pure Appl. Chem.
, vol.59
, pp. 181-192
-
-
Reedijk, J.1
-
3
-
-
0026594392
-
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
-
Godwin, A. K., Meister, A., O'Dwyer, P. J., Huung, C. S., Hamilton, T. C., and Anderson, M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad, Sci. USA, 89: 3070-3074, 1992.
-
(1992)
Proc. Natl. Acad, Sci. USA
, vol.89
, pp. 3070-3074
-
-
Godwin, A.K.1
Meister, A.2
O'Dwyer, P.J.3
Huung, C.S.4
Hamilton, T.C.5
Anderson, M.E.6
-
4
-
-
0027423911
-
Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines
-
Hamaguchi, K., Godwin, A. K., Yakushiji, M., O'Dwyer, P. J., Ozols, R. F., and Hamilton, T. C. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res., 53: 5225-5232, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 5225-5232
-
-
Hamaguchi, K.1
Godwin, A.K.2
Yakushiji, M.3
O'Dwyer, P.J.4
Ozols, R.F.5
Hamilton, T.C.6
-
5
-
-
0028326742
-
Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
-
Johnson, S. W., Perez, R. P., Godwin, A. K., Yeung, A. T., Handel, L. M., Ozols, R. F., and Hamilton, T. C. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem. Pharmacol., 47: 689-697, 1994.
-
(1994)
Biochem. Pharmacol.
, vol.47
, pp. 689-697
-
-
Johnson, S.W.1
Perez, R.P.2
Godwin, A.K.3
Yeung, A.T.4
Hel, L.M.5
Ozols, R.F.6
Hamilton, T.C.7
-
6
-
-
0027939445
-
Relationship between platinum-DNA adduct formation removal and cisplatin cytotoxicity in cisplatin-sensitive and - Resistant human ovarian cancer cells
-
Johnson, S. W., Swiggard, P. A., Handel, L. M., Brennan, J. M., Godwin, A. K., Ozols, R. F., and Hamilton, T. C. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and - resistant human ovarian cancer cells. Cancer Res., 54: 5911-5916, 1994.
-
(1994)
Cancer Res.
, vol.54
, pp. 5911-5916
-
-
Johnson, S.W.1
Swiggard, P.A.2
Handel, L.M.3
Brennan, J.M.4
Godwin, A.K.5
Ozols, R.F.6
Hamilton, T.C.7
-
7
-
-
0024595042
-
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
-
Hansen, M. B., Nielsen, S. E., and Berg, K. J. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Immunol. Methods, 119: 203-210, 1989.
-
(1989)
Immunol. Methods
, vol.119
, pp. 203-210
-
-
Hansen, M.B.1
Nielsen, S.E.2
Berg, K.J.3
-
8
-
-
0019167355
-
Determination of glututhione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine
-
Griffith, O. W. Determination of glututhione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine. Anal. Biochem., 106: 207-212, 1980.
-
(1980)
Anal. Biochem.
, vol.106
, pp. 207-212
-
-
Griffith, O.W.1
-
9
-
-
0002601141
-
Multiple regression
-
J. C Fry (ed.). New York: Oxford University Press
-
Iles. T. C. Multiple regression. In: J. C Fry (ed.). Biological Data Analysis: A Practical Approach, pp, 127-172. New York: Oxford University Press, 1993.
-
(1993)
Biological Data Analysis: a Practical Approach
, pp. 127-172
-
-
Iles, T.C.1
-
10
-
-
0027238859
-
Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
-
Lopes, N. M., Adams, E. G., Pitts, T. W., and Bhuyan, B. K. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother. Pharmacol., 32: 235-242, 1993.
-
(1993)
Cancer Chemother. Pharmacol.
, vol.32
, pp. 235-242
-
-
Lopes, N.M.1
Adams, E.G.2
Pitts, T.W.3
Bhuyan, B.K.4
-
11
-
-
1842299060
-
-
Norwalk, CT: Appleton and Lange
-
Dawson-Saunders, B., and Trapp, R. G. Basic and Clinical Biostatistics, Ed. 2, pp. 167-169, Norwalk, CT: Appleton and Lange, 1994.
-
(1994)
Basic and Clinical Biostatistics, Ed. 2
, pp. 167-169
-
-
Dawson-Saunders, B.1
Trapp, R.G.2
-
12
-
-
0025113422
-
Resistance to alkylating agents and cisplatin: Insights from ovarian carcinoma model systems
-
Perez, R. P., Hamilton, T. C., and Ozols, R. F. Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems. Pharmacol. Ther., 48: 19-27, 1990.
-
(1990)
Pharmacol. Ther.
, vol.48
, pp. 19-27
-
-
Perez, R.P.1
Hamilton, T.C.2
Ozols, R.F.3
-
13
-
-
0023183762
-
Decreased cisplatin uptake by resistant L1210 leukemia cells
-
Hromas, R. A., North, J. A., and Burns, C. P. Decreased cisplatin uptake by resistant L1210 leukemia cells. Cancer Lett., 36: 197-201, 1987.
-
(1987)
Cancer Lett.
, vol.36
, pp. 197-201
-
-
Hromas, R.A.1
North, J.A.2
Burns, C.P.3
-
14
-
-
0023597598
-
Differential uptake of cis-diamminedichloroplatinum(II) by sensitive and resistant murine L1210 leukemia cells
-
Waud, W. R. Differential uptake of cis-diamminedichloroplatinum(II) by sensitive and resistant murine L1210 leukemia cells. Cancer Res., 47: 6549-6555, 1987.
-
(1987)
Cancer Res.
, vol.47
, pp. 6549-6555
-
-
Waud, W.R.1
-
15
-
-
0023238688
-
Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II)
-
Richon, V. M., Schulte, N., and Eastman, A. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II). Cancer Res., 47: 2056-2061, 1987.
-
(1987)
Cancer Res.
, vol.47
, pp. 2056-2061
-
-
Richon, V.M.1
Schulte, N.2
Eastman, A.3
-
16
-
-
0023141518
-
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)
-
Teicher, B. A., Holden, S. A., Kelley, M. J., Shea, T. C., Cucchi, C. A., Rosowsky, A., Henner, W. D., and Frei, E., III. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res., 47: 388-393, 1987.
-
(1987)
Cancer Res.
, vol.47
, pp. 388-393
-
-
Teicher, B.A.1
Holden, S.A.2
Kelley, M.J.3
Shea, T.C.4
Cucchi, C.A.5
Rosowsky, A.6
Henner, W.D.7
Frei III, E.8
-
17
-
-
0023875417
-
Cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells
-
Andrews, P. A., Velury, S., Mann, S. C., and Howell, S. B. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48: 68-73, 1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 68-73
-
-
Andrews, P.A.1
Velury, S.2
Mann, S.C.3
Howell, S.B.4
-
18
-
-
0023882049
-
Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro
-
Kraker, A. J., and Moore, C. W. Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. Cancer Res., 48: 9-13, 1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 9-13
-
-
Kraker, A.J.1
Moore, C.W.2
-
19
-
-
0023889564
-
Cis-Diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines
-
Kuppen, P. J. K., Schuitemaker, H., van't Veer, L. J., de Bruijn, E. A., van Oosterom, A. T., and Schrier, P. I. cis-Diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines. Cancer Res., 48: 3355-3359, 1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 3355-3359
-
-
Kuppen, P.J.K.1
Schuitemaker, H.2
Van't Veer, L.J.3
De Bruijn, E.A.4
Van Oosterom, A.T.5
Schrier, P.I.6
-
20
-
-
0026692952
-
Mechanism-related circumvention of acquired cis-diamminedichloro- Platinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum IV dicarboxylates
-
Kelland, L. R., Mistry, P., Abel, G., Loh, S. Y., O'Neill, C. F., Murrer, B. A., and Harrap, K. R. Mechanism-related circumvention of acquired cis-diamminedichloro- platinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum IV dicarboxylates. Cancer Res., 52: 3857-3864, 1992.
-
(1992)
Cancer Res.
, vol.52
, pp. 3857-3864
-
-
Kelland, L.R.1
Mistry, P.2
Abel, G.3
Loh, S.Y.4
O'Neill, C.F.5
Murrer, B.A.6
Harrap, K.R.7
-
21
-
-
0030578452
-
Cross-resistance, cisplatin accumulation and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines
-
Johnson, S. W., Shen, D-W., Pastan, I., Gottesman, M. M., and Hamilton, T. C. Cross-resistance, cisplatin accumulation and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines. Exp. Cell Res., 226: 133-139, 1996.
-
(1996)
Exp. Cell Res.
, vol.226
, pp. 133-139
-
-
Johnson, S.W.1
Shen, D.-W.2
Pastan, I.3
Gottesman, M.M.4
Hamilton, T.C.5
-
22
-
-
0027233829
-
Cellular accumulation of the anticancer agent cisplatin: A review
-
Gately, D. P., and Howell, S. B. Cellular accumulation of the anticancer agent cisplatin: a review. Br. J. Cancer. 67: 1171-1175, 1993.
-
(1993)
Br. J. Cancer.
, vol.67
, pp. 1171-1175
-
-
Gately, D.P.1
Howell, S.B.2
-
23
-
-
0027305406
-
Glutathione-associated cis-diarnminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells
-
Ishikawa, T., and Ali-Osman, F. Glutathione-associated cis-diarnminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. J. Biol. Chem., 268: 20116-20125, 1993.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 20116-20125
-
-
Ishikawa, T.1
Ali-Osman, F.2
-
24
-
-
0027358686
-
Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian carcinoma cell lines
-
Mistry, P., Loh, S. Y., Kelland, L. R., and Harrap, K. R. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian carcinoma cell lines. Int. J. Cancer, 55: 848-856, 1993.
-
(1993)
Int. J. Cancer
, vol.55
, pp. 848-856
-
-
Mistry, P.1
Loh, S.Y.2
Kelland, L.R.3
Harrap, K.R.4
-
25
-
-
0025124156
-
An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumor agents shown by a range of human tumour cell lines
-
Hosking, L. K., Whelan, R. D. H., Shellard, S. A., Bedford, P., and Hill, B. T. An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumor agents shown by a range of human tumour cell lines. Biochem. Pharmacol., 40: 1833-1842, 1990.
-
(1990)
Biochem. Pharmacol.
, vol.40
, pp. 1833-1842
-
-
Hosking, L.K.1
Whelan, R.D.H.2
Shellard, S.A.3
Bedford, P.4
Hill, B.T.5
-
26
-
-
0027532901
-
The role of metallothionein. glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents
-
Hrubisko, M., McGown, A. T., and Fox, B. W. The role of metallothionein. glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents. Biochem. Pharmacol., 45: 253-256, 1993.
-
(1993)
Biochem. Pharmacol.
, vol.45
, pp. 253-256
-
-
Hrubisko, M.1
McGown, A.T.2
Fox, B.W.3
-
27
-
-
0025816320
-
The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines
-
Mistry, P., Kelland, L. R., Abel, G., Sidhar, S., and Harrap, K. R. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br. J. Cancer. 64: 215-220, 1991.
-
(1991)
Br. J. Cancer.
, vol.64
, pp. 215-220
-
-
Mistry, P.1
Kelland, L.R.2
Abel, G.3
Sidhar, S.4
Harrap, K.R.5
-
28
-
-
0029056498
-
Intracellular glutathione and cytotoxicity of platinum complexes
-
Pendyala, L., Creaven, P. J., Ferez, R., Zdanowicz, J. R., and Raghavan, D. Intracellular glutathione and cytotoxicity of platinum complexes. Cancer Chemother. Pharmacol., 36: 271-278, 1995.
-
(1995)
Cancer Chemother. Pharmacol.
, vol.36
, pp. 271-278
-
-
Pendyala, L.1
Creaven, P.J.2
Ferez, R.3
Zdanowicz, J.R.4
Raghavan, D.5
-
29
-
-
0023750017
-
Increased DNA repair as a mechanism of acquired resistance to cis-diamrninedichloroplatinum(II) in human ovarian cancer cell lines
-
Masuda, H., Ozols, R. F., Lai, G-M., Fojo, A., Rothenberg, M., and Hamilton, T. C. Increased DNA repair as a mechanism of acquired resistance to cis-diamrninedichloroplatinum(II) in human ovarian cancer cell lines. Cancer Res., 48: 5713-5716, 1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 5713-5716
-
-
Masuda, H.1
Ozols, R.F.2
Lai, G.-M.3
Fojo, A.4
Rothenberg, M.5
Hamilton, T.C.6
-
30
-
-
0024238957
-
Enhanced DNA repair and resistance to cisplatin in human ovarian cancer
-
Lai, G-M., Ozols, R. F., Smyth, J. F., Young, R. C., and Hamilton, T. C. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem. Pharmacol., 37: 4597-4600, 1988.
-
(1988)
Biochem. Pharmacol.
, vol.37
, pp. 4597-4600
-
-
Lai, G.-M.1
Ozols, R.F.2
Smyth, J.F.3
Young, R.C.4
Hamilton, T.C.5
-
31
-
-
0023718434
-
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
-
Eastman, A., and Schulte, N. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry, 27: 4730-4734, 1988.
-
(1988)
Biochemistry
, vol.27
, pp. 4730-4734
-
-
Eastman, A.1
Schulte, N.2
-
32
-
-
0025271094
-
Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II)
-
Masuda, H., Tanaka, T., Matsuda, H., and Kusaba, I. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res., 50: 1863-1866, 1990.
-
(1990)
Cancer Res.
, vol.50
, pp. 1863-1866
-
-
Masuda, H.1
Tanaka, T.2
Matsuda, H.3
Kusaba, I.4
-
33
-
-
0025775323
-
Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation
-
Parker, R. J., Eastman, A., Bostick-Bruton, F., and Reed, E. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J. Clin. Invest., 87: 772-777, 1991.
-
(1991)
J. Clin. Invest.
, vol.87
, pp. 772-777
-
-
Parker, R.J.1
Eastman, A.2
Bostick-Bruton, F.3
Reed, E.4
-
34
-
-
0026737805
-
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines
-
Zhcn, W., Link, C. J., Jr., O'Connor, P. M., Reed, E., Parker, P., Howell, S. B., and Bohr. V. A. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol. Cell. Biol., 12: 3689-3698, 1992.
-
(1992)
Mol. Cell. Biol.
, vol.12
, pp. 3689-3698
-
-
Zhcn, W.1
Link Jr., C.J.2
O'Connor, P.M.3
Reed, E.4
Parker, P.5
Howell, S.B.6
Bohr, V.A.7
-
35
-
-
0028018956
-
Studying nucleotide excision repair of mammalian DNA in a cell-free system
-
Wood, R. D. Studying nucleotide excision repair of mammalian DNA in a cell-free system. Ann. NY Acad. Sci., 726: 274-280, 1994.
-
(1994)
Ann. NY Acad. Sci.
, vol.726
, pp. 274-280
-
-
Wood, R.D.1
-
36
-
-
0025335324
-
Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum(II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation
-
Hill, B. T., Shellard, S. A., Hosking, L. K., Fichtinger-Schepman, A. M. J., and Bedford, P. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum(II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. Int. J. Radiat. Oncol. Biol. Phys., 19: 75-83, 1990.
-
(1990)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.19
, pp. 75-83
-
-
Hill, B.T.1
Shellard, S.A.2
Hosking, L.K.3
Fichtinger-Schepman, A.M.J.4
Bedford, P.5
-
37
-
-
0024507191
-
Pathways of human cell post-replication repair
-
Kaufmann, W. K. Pathways of human cell post-replication repair. Carcinogenesis (Lond.), 10: 1-11, 1989.
-
(1989)
Carcinogenesis (Lond.)
, vol.10
, pp. 1-11
-
-
Kaufmann, W.K.1
-
38
-
-
0028304413
-
Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines
-
Mamenta, E. L., Poma, E. E., Kaufmann, W. K., Delmastro, D. A., Grady, H. L., and Chancy, S. G. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res., 54: 3500-3505, 1994.
-
(1994)
Cancer Res.
, vol.54
, pp. 3500-3505
-
-
Mamenta, E.L.1
Poma, E.E.2
Kaufmann, W.K.3
Delmastro, D.A.4
Grady, H.L.5
Chancy, S.G.6
-
39
-
-
0029068148
-
DNA polymerase B bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene
-
Hoffmann, J-S., Pillaire, M-J., Maga, G., Podust, V., Hubscher, U., and Villani, G. DNA polymerase B bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene. Proc. Natl. Acad. Sci. USA, 92: 5356-5360, 1995.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 5356-5360
-
-
Hoffmann, J.-S.1
Pillaire, M.-J.2
Maga, G.3
Podust, V.4
Hubscher, U.5
Villani, G.6
-
41
-
-
0028071123
-
Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard
-
O'Connor, P. M., Ferris, D. K., Hoffmann, I., Jackman, J., Draetta, G., and Kohn, K. W. Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc. Natl. Acad. Sci. USA, 91: 9480-9484, 1994.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 9480-9484
-
-
O'Connor, P.M.1
Ferris, D.K.2
Hoffmann, I.3
Jackman, J.4
Draetta, G.5
Kohn, K.W.6
-
42
-
-
0028094424
-
The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells
-
Demarcq, C., Bunch, R. T., Creswell, D., and Eastman, A. The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth & Differ., 5: 983-993, 1994.
-
(1994)
Cell Growth & Differ.
, vol.5
, pp. 983-993
-
-
Demarcq, C.1
Bunch, R.T.2
Creswell, D.3
Eastman, A.4
-
43
-
-
0029058436
-
Cisplatin resistance in a murine leukemia cell line is associated with a detective apoptotic process
-
Segal-Bendirdjian, E., and Jacquemin-Sablon, A. Cisplatin resistance in a murine leukemia cell line is associated with a detective apoptotic process. Exp. Cell Res., 218: 201-212, 1995.
-
(1995)
Exp. Cell Res.
, vol.218
, pp. 201-212
-
-
Segal-Bendirdjian, E.1
Jacquemin-Sablon, A.2
-
44
-
-
0027389763
-
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
-
Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
-
(1993)
Blood
, vol.81
, pp. 151-157
-
-
Miyashita, T.1
Reed, J.C.2
-
45
-
-
0028982183
-
Expression of Bcl-XL can confer a multidrug resistant phenotype
-
Minn, A. J., Rudin, C. M., Boise, L. H., and Thompson, C. B. Expression of Bcl-XL can confer a multidrug resistant phenotype. Blood, 86: 1903-1910, 1995.
-
(1995)
Blood
, vol.86
, pp. 1903-1910
-
-
Minn, A.J.1
Rudin, C.M.2
Boise, L.H.3
Thompson, C.B.4
-
46
-
-
0023901469
-
Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes
-
Sklar, M. D. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res., 48: 793-797, 1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 793-797
-
-
Sklar, M.D.1
-
47
-
-
0026354764
-
Expression of the c-Ha-Ras oncogene induces resistance to cisplatin
-
Isonishi, S., Horn, D. K., Thiebaut, F. B., Mann, S. C., Andrews, P. A., Basu, A., Lazo, J. S., Eastman, A., and Howell, S. B. Expression of the c-Ha-Ras oncogene induces resistance to cisplatin. Cancer Res., 57: 5903-5905, 1991.
-
(1991)
Cancer Res.
, vol.57
, pp. 5903-5905
-
-
Isonishi, S.1
Horn, D.K.2
Thiebaut, F.B.3
Mann, S.C.4
Andrews, P.A.5
Basu, A.6
Lazo, J.S.7
Eastman, A.8
Howell, S.B.9
-
48
-
-
0029155807
-
Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase
-
Chapman, R. S., Whetton, A. D., Chresta, C. M., and Dive, C. Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase. Mol. Pharmacol., 48: 334-343, 1995.
-
(1995)
Mol. Pharmacol.
, vol.48
, pp. 334-343
-
-
Chapman, R.S.1
Whetton, A.D.2
Chresta, C.M.3
Dive, C.4
-
49
-
-
0027074588
-
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
-
Benz, C. C., Scott, G. K., Sarup, J. C., Johnson, R. M., Tripathy, D., Coronado, E., Shepard, H. M., and Osborne, C. K. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat., 24: 85-95, 1992.
-
(1992)
Breast Cancer Res. Treat.
, vol.24
, pp. 85-95
-
-
Benz, C.C.1
Scott, G.K.2
Sarup, J.C.3
Johnson, R.M.4
Tripathy, D.5
Coronado, E.6
Shepard, H.M.7
Osborne, C.K.8
-
50
-
-
0028880293
-
The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2
-
Eliopoulos, A. G., Kerr, D. J., Herod, J., Hodgkins, L., Krajewski, S., Reed, J. C., and Young, L. S. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene, 11: 1217-1228, 1995.
-
(1995)
Oncogene
, vol.11
, pp. 1217-1228
-
-
Eliopoulos, A.G.1
Kerr, D.J.2
Herod, J.3
Hodgkins, L.4
Krajewski, S.5
Reed, J.C.6
Young, L.S.7
|